Age Alone Is Not a Barrier to Concurrent Chemoradiotherapy for Advanced Head and Neck Cancer

被引:0
作者
Sexton, Gerard P. [1 ,2 ]
Walsh, Paul [3 ]
Moriarty, Frank [2 ,4 ]
O'Neill, James Paul [1 ,2 ]
机构
[1] Beaumont Hosp, Dept Otolaryngol Head & Neck Surg, Beaumont Rd, Dublin 9, Ireland
[2] Royal Coll Surgeons Ireland, Dublin, Ireland
[3] Natl Canc Registry Ireland, Cork Airport Business Pk, Cork, Ireland
[4] Royal Coll Surgeons Ireland, Sch Pharm & Biomol Sci, Dublin, Ireland
关键词
head and neck cancer; elderly; concurrent chemoradiotherapy; chemotherapy; survival; SQUAMOUS-CELL CARCINOMA; NEOADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; RADIOTHERAPY; UPDATE;
D O I
10.1177/00034894221086087
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Head and Neck Cancer (HNC) is associated with significant morbidity and mortality, especially when high stage disease is present. There exists a range of options for the management of locoregionally advanced HNC, though doubt remains as to the optimal strategy in the elderly population. Aims: To evaluate the benefits imparted by concurrent chemoradiotherapy (CCRT) to the elderly population of HNC patients in Ireland. Methods: A retrospective cohort study was conducted using 20 years of cancer registry data provided by the National Cancer Registry of Ireland. Cox multivariate regression analysis was applied to test for the benefits of CCRT in HNC. Results: Survival analysis showed an overall benefit to the use of CCRT in patients with advanced disease over 70 years, particularly when used for hypopharyngeal, oropharyngeal, and laryngeal malignancy. There was a benefit to cancer-specific but not all-cause mortality in those over 75 years, and no benefit was observed to the addition of chemotherapy in those over 80 years; only 8 patients over 80 received CCRT. There was no statistically significant difference in the benefits derived by those over 70 years relative to those under 70 years. Conclusion: CCRT confers significant survival benefits to appropriately selected elderly HNC patients and should therefore not be withheld solely on the basis of age.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 36 条
[1]   Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology [J].
Alterio, D. ;
Rocca, M. Cossu ;
Russell-Edu, W. ;
Dicuonzo, S. ;
Fanetti, G. ;
Marvaso, G. ;
Preda, L. ;
Zorzi, S. ;
Verri, E. ;
Nole', F. ;
Jereczek-Fossa, B. A. .
MEDICAL ONCOLOGY, 2017, 34 (05)
[2]  
Amin MB., 2017, AJCC CANC STAGING MA, V8th
[3]   Survival Outcomes With Concurrent Chemoradiation for Elderly Patients With Locally Advanced Head and Neck Cancer According to the National Cancer Data Base [J].
Amini, Arya ;
Jones, Bernard L. ;
McDermott, Jessica D. ;
Serracino, Hilary S. ;
Jimeno, Antonio ;
Raben, David ;
Ghosh, Debashis ;
Bowles, Daniel W. ;
Karam, Sana D. .
CANCER, 2016, 122 (10) :1533-1543
[4]   Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer [J].
Bernier, J ;
Domenge, C ;
Ozsahin, M ;
Matuszewska, K ;
Lefèbvre, JL ;
Greiner, RH ;
Giralt, J ;
Maingon, P ;
Rolland, F ;
Bolla, M ;
Cognetti, F ;
Bourhis, J ;
Kirkpatrick, A ;
van Glabbeke, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1945-1952
[5]   Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis [J].
Blanchard, Pierre ;
Lee, Anne ;
Marguet, Sophie ;
Leclercq, Julie ;
Ng, Wai Tong ;
Ma, Jun ;
Chan, Anthony T. C. ;
Huang, Pei-Yu ;
Benhamou, Ellen ;
Zhu, Guopei ;
Chua, Daniel T. T. ;
Chen, Yong ;
Mai, Hai-Qiang ;
Kwong, Dora L. W. ;
Cheah, Shie Lee ;
Moon, James ;
Tung, Yuk ;
Chi, Kwan-Hwa ;
Fountzilas, George ;
Zhang, Li ;
Hui, Edwin Pun ;
Lu, Tai-Xiang ;
Bourhis, Jean ;
Pignon, Jean Pierre .
LANCET ONCOLOGY, 2015, 16 (06) :645-655
[6]   Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival [J].
Bonner, James A. ;
Harari, Paul M. ;
Giralt, Jordi ;
Cohen, Roger B. ;
Jones, Christopher U. ;
Sur, Ranjan K. ;
Raben, David ;
Baselga, Jose ;
Spencer, Sharon A. ;
Zhu, Junming ;
Youssoufian, Hagop ;
Rowinsky, Eric K. ;
Ang, K. Kian .
LANCET ONCOLOGY, 2010, 11 (01) :21-28
[7]   Head and Neck Cancer and the Elderly Patient [J].
Cervenka, Brian P. ;
Rao, Shyam ;
Bewley, Arnaud F. .
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2018, 51 (04) :741-+
[8]   The role of age in treatment-related adverse events in patients with head and neck cancer: A systematic review [J].
Coca-Pelaz, Andres ;
Halmos, Gyorgy B. ;
Strojan, Primoz ;
de Bree, Remco ;
Bossi, Paolo ;
Bradford, Carol R. ;
Rinaldo, Alessandra ;
Vander Poorten, Vincent ;
Sanabria, Alvaro ;
Takes, Robert P. ;
Ferlito, Alfio .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (07) :2410-2429
[9]   Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck [J].
Cooper, JS ;
Pajak, TF ;
Forastiere, AA ;
Jacobs, J ;
Campbell, BH ;
Saxman, SB ;
Kish, JA ;
Kim, HE ;
Cmelak, AJ ;
Rotman, M ;
Machtay, M ;
Ensley, JF ;
Chao, KSC ;
Schultz, CJ ;
Lee, N ;
Fu, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1937-1944
[10]   Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma [J].
Domenge, C ;
Hill, C ;
Lefebvre, JL ;
De Raucourt, D ;
Rhein, B ;
Wibault, P ;
Marandas, P ;
Coche-Dequeant, B ;
Stromboni-Luboinski, M ;
Sancho-Garnier, H ;
Luboinski, B .
BRITISH JOURNAL OF CANCER, 2000, 83 (12) :1594-1598